Justin Chakma
Chief Business OfficerMr. Justin Chakma serves as Chief Business Officer at ARS Pharmaceuticals, Inc. since June 2019. He was previously VP, Head of Business Development and Strategy at Vedanta Biosciences Before that, he was a Senior Director of Business Development at Celgene (acquired by BMS) focused on immunology and neuroscience. He held various roles in business development, financing and venture capital at Receptos (acquired by Celgene), Auspex (acquired by Teva) and Thomas, McNerney & Partners. He served as Associate at Thomas, McNerney & Partners. Mr. Chakma joined Thomas, McNerney & Partners in 2012, having previously conducted research in support of the Bill and Melinda Gates Foundation. He has published multiple articles on healthcare innovation in peer-reviewed journals, including the New England Journal of Medicine. He holds an MBA from the Wharton School of the University of Pennsylvania and a Hon. B.A. in neuroscience and economics from the University of Toronto.
Positions
- Company NameARS Pharmaceuticals, Inc.Stock CodeSPRYPositionChief Business OfficerColleagues
- PSPratik ShahChairman of the Board
- DCDonn CasaleCEO, President & Director
- RBRobert BellCo-Founder & Chief Science Officer
- KDKathleen D. ScottChief Financial Officer
- BTBrian T. DorseyChief Operating Officer
- PKPeter KolchinskyIndependent Director
- PMPhillip M. SchneiderIndependent Director
- SISaqib IslamIndependent Director
